Trial Profile
Phase II proof-of-concept trial of valproic acid [Avugane] in patients with mild-to-moderate acne vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2015
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary) ; Isotretinoin
- Indications Acne vulgaris
- Focus Adverse reactions; Therapeutic Use
- 23 Apr 2015 New trial record